Are Man Boobs Genetic? Causes and Treatments

Are man boobs genetic? Genetics can play a role in gynaecomastia, the medical term for enlarged breast tissue in men, but inherited factors are rarely the sole cause. Hormonal imbalances, certain medications, underlying health conditions, and lifestyle factors all contribute. This article explains how genes interact with other causes, how true gynaecomastia differs from excess chest fat, what treatments are available on the NHS and privately, and when to seek medical advice.

Are man boobs actually caused by your genes?

Genetics can increase susceptibility to gynaecomastia through inherited variations in oestrogen receptors and androgen sensitivity, but a clear genetic cause is only firmly established in conditions such as Klinefelter syndrome; most cases involve multiple factors.

Genetics can contribute to the development of gynaecomastia, the medical term for enlarged breast tissue in men, but genes alone rarely tell the whole story. Some inherited variations affecting oestrogen receptors, androgen sensitivity, and the enzymes that convert androgens to oestrogens are thought to increase susceptibility to the condition, though the evidence base for familial clustering outside defined genetic syndromes remains limited. If a close male relative has experienced gynaecomastia, your own risk may be modestly elevated, but this has not been precisely quantified in most cases.

A genetic predisposition does not mean the condition is inevitable, nor does it mean that lifestyle or medical factors are irrelevant. Most cases of gynaecomastia arise from a hormonal imbalance between oestrogen and testosterone, and this imbalance can be influenced by a wide range of factors beyond inherited traits. Genetics may lower the threshold at which that imbalance produces visible breast tissue, but the trigger is often something else entirely. It is also worth noting that, even after a thorough clinical assessment, no single cause is identified in a significant proportion of men; these cases are described as idiopathic.

A family history of conditions such as Klinefelter syndrome, a chromosomal variation in which men carry an extra X chromosome, is associated with a significantly higher likelihood of gynaecomastia.^[2][3] In such cases, the genetic link is direct and well established. For most men, though, the picture is more nuanced, and a thorough clinical assessment is needed to understand the underlying cause rather than attributing the condition solely to heredity.

What is the difference between gynaecomastia and excess chest fat?

Gynaecomastia is growth of firm glandular tissue beneath the nipple, while pseudogynaecomastia is soft excess fat across the chest; the distinction determines treatment, as only pseudogynaecomastia reliably responds to weight loss and exercise.

Gynaecomastia is the growth of actual glandular breast tissue in men, whereas excess chest fat, sometimes called pseudogynaecomastia, is simply an accumulation of adipose tissue in the chest area without any glandular involvement. The distinction matters clinically because the two conditions have different causes, different implications, and different treatment pathways.

Glandular tissue in gynaecomastia typically feels firm or rubbery and is located directly beneath the nipple and areola.^[1] It may be tender or sensitive to touch, particularly in the early stages when the tissue is actively growing. Pseudogynaecomastia, by contrast, tends to feel softer and is more evenly distributed across the chest, following the general pattern of body fat. It is not usually tender.

A GP or specialist can often distinguish between the two through physical examination alone. Where clinical uncertainty remains, imaging is usually arranged: ultrasound is the most common first-line investigation, and mammography may be used in selected cases, for example where there is concern about an underlying breast lesion.^[13][14] Blood tests to assess hormone levels are commonly arranged when true gynaecomastia is suspected. It is possible for both conditions to coexist, meaning a man may have both glandular enlargement and overlying excess fat, which can make the chest appear more prominent than either condition would produce on its own.

Understanding which type is present is important because pseudogynaecomastia generally responds to weight loss and exercise, whereas true gynaecomastia may persist even after significant weight reduction and may require medical or surgical intervention.

What other factors can cause or worsen the condition?

Medications, hormonal conditions such as hypogonadism, liver disease, obesity, and heavy alcohol use are common non-genetic causes that raise oestrogen relative to testosterone and can trigger or worsen gynaecomastia.

Beyond genetics, a range of hormonal, pharmacological, and lifestyle factors can cause or worsen gynaecomastia. The most common underlying mechanism is an imbalance between oestrogen and testosterone, and anything that raises oestrogen levels or reduces testosterone activity relative to oestrogen can tip the balance towards breast tissue growth. Hypogonadism, whether primary (testicular failure) or secondary (pituitary or hypothalamic in origin), is an important and directly treatable cause of low testosterone that should be considered during assessment.

Medications are a particularly important and often overlooked cause. Drugs known to be associated with gynaecomastia include:^[1]

• Spironolactone (used for heart failure and fluid retention)

• Cimetidine (a stomach acid reducer)

• Anti-androgens such as bicalutamide, used in prostate cancer treatment

• 5-alpha-reductase inhibitors such as finasteride and dutasteride, used for benign prostatic hyperplasia and hair loss^[10][11]

• GnRH analogues, used in prostate cancer and other hormone-sensitive conditions

• Anabolic steroids, which paradoxically convert to oestrogen in the body

• Certain antipsychotics, particularly risperidone, which raises prolactin levels and can suppress testosterone; the association with antidepressants is less well established^[6][7]

• Certain antiretroviral medicines used in HIV treatment

• Digoxin and some other cardiac medicines

If you have recently started a new medicine and notice chest changes, it is worth discussing this with your GP or pharmacist before stopping any treatment. Suspected side effects from medicines can also be reported to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk.

Medical conditions that affect hormone balance can also play a role. These include liver disease, kidney failure, hyperthyroidism, and tumours of the testes or adrenal glands. Obesity itself raises oestrogen levels because fat tissue converts androgens to oestrogens through a process called peripheral aromatisation, which can worsen both true gynaecomastia and pseudogynaecomastia.^[1]

Alcohol use, particularly heavy or long-term consumption, is associated with liver changes that impair oestrogen metabolism. Cannabis use has also been linked to gynaecomastia in some studies, though the evidence is inconsistent and should be regarded as inconclusive. Puberty and older age are two life stages where hormonal fluctuations naturally increase the risk. Pubertal gynaecomastia commonly regresses within 6 to 24 months without treatment. Age-related gynaecomastia, by contrast, may persist and is less likely to resolve spontaneously.

When should you see a GP about chest swelling or tenderness?

See a GP promptly if you notice a hard or irregular lump, nipple discharge, skin changes, or rapidly enlarging one-sided swelling, as these features may warrant an urgent two-week-wait referral under NICE guidance NG12.

You should see a GP if you notice new or worsening swelling, firmness, or tenderness in one or both sides of your chest, particularly if it has developed over a short period or is accompanied by other symptoms. While gynaecomastia is usually benign, a clinical assessment is important to rule out rarer but more serious causes, including male breast cancer, which, although uncommon, does occur.

Features that warrant prompt GP review, and which may lead to an urgent two-week-wait referral in line with NICE guidance on suspected cancer (NG12), include:

• A hard, irregular, or fixed lump in the breast tissue, especially if it is not centred beneath the nipple

• Nipple discharge, particularly if it is bloodstained

• Nipple inversion or skin changes such as dimpling or puckering of the overlying skin

• Swelling in only one breast that is rapidly enlarging

• Swollen lymph nodes in the armpit on the same side

• Associated symptoms such as unexplained weight loss, fatigue, or testicular changes

• Breast changes in a child or adolescent that persist beyond two years after the onset of puberty

For most men, gynaecomastia is not dangerous, but it can cause significant psychological distress, including reduced confidence and avoidance of activities such as swimming. This alone is a valid reason to seek a GP appointment. Your GP can arrange blood tests to check hormone levels, liver and kidney function, and thyroid function, and can refer you to an endocrinologist or breast surgeon if needed.

For urgent advice when you are unsure what to do, or when your GP surgery is closed, NHS 111 is available by phone or online. For routine concerns such as this, booking a GP appointment is the appropriate first step. If you experience sudden severe chest pain or difficulty breathing alongside chest swelling, call 999 immediately.

What treatment options are available on the NHS and privately?

NHS surgical correction is not routinely funded and depends on local ICB criteria; options include liposuction, surgical excision of glandular tissue, or both, with tamoxifen used off-licence in specialist settings for recent-onset cases.

Treatment for gynaecomastia depends on the underlying cause, the severity of the condition, and how long it has been present. Where a reversible cause is identified, such as a medication or an underlying medical condition, addressing that cause is the first step. Reviewing or substituting a causative medicine (where clinically safe to do so) should always be considered before other interventions, and watchful waiting is appropriate for pubertal gynaecomastia, which commonly resolves within 6 to 24 months.

On the NHS, treatment pathways are guided by NICE and local Integrated Care Board (ICB) commissioning decisions. Surgical correction of gynaecomastia is generally considered a cosmetic procedure and is not routinely funded by the NHS unless there is a significant functional or psychological impact that meets locally defined clinical thresholds.^[1] Eligibility criteria vary between ICBs, so it is worth discussing your specific circumstances with your GP.

Where surgery is indicated, the options include:

• Liposuction, which removes excess fat but does not excise glandular tissue, and is most appropriate where fat rather than firm glandular tissue predominates

• Surgical excision of glandular tissue (sometimes called subcutaneous mastectomy), which is required where firm breast tissue is present and is the definitive treatment for true gynaecomastia

• A combination of both, which is often used when both fat and glandular tissue are present

Medical treatments are less commonly used but may be considered in certain cases. Tamoxifen, a selective oestrogen receptor modulator, has been used off-licence in some specialist settings to reduce glandular tissue. It is most likely to be effective in recent-onset or painful gynaecomastia and is not licensed specifically for this indication in the UK.^[19][20] Its use should be initiated and supervised by a specialist.

For men exploring weight management as part of addressing pseudogynaecomastia or obesity-related hormonal changes, Bolt Pharmacy is a GPhC-registered UK online pharmacy offering online weight-management consultations, with prescriber review and pharmacist support, where clinically appropriate options may be considered alongside lifestyle guidance. Privately, surgical correction is available through a number of accredited plastic surgery providers, and costs vary considerably depending on the procedure and the clinic.

Scientific References

1. Gynaecomastia.
2. Klinefelter's Syndrome.
3. Klinefelter Syndrome. JAMA Internal Medicine..
4. Oncologic manifestations of Klinefelter syndrome. Hormones (Athens)..
5. Risk factors for male breast cancer (United States). Cancer Causes & Control..
6. Prolactogenic effects of risperidone in male patients..
7. Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management. Drugs..
8. Antipsychotic-drug-induced hyperprolactinemia: physiopathology, clinical features and guidance. L'Encephale..
9. Gynecomastia and cannabis smoking. A nonassociation..
10. A Review of the FAERS Data on 5-Alpha Reductase Inhibitors: Implications for Postfinasteride Syndrome. Urology..
11. A 5-year retrospective analysis of 5α-reductase inhibitors in men with benign prostatic hyperplasia: finasteride vs dutasteride. International Journal of Clinical Practice..
12. The REDUCE trial: chemoprevention in prostate cancer using dutasteride. Expert Review of Anticancer Therapy..
13. Is Breast Imaging in Male Patients With Benign Lumps Necessary? European Journal of Breast Health..
14. ACR Appropriateness Criteria: Evaluation of the Symptomatic Male Breast. Journal of the American College of Radiology..
15. Suspected cancer: recognition and referral (NG12).
16. Tamoxifen. British National Formulary..
17. Tamoxifen for breast cancer.
18. Tamoxifen 20mg Film-Coated Tablets. Summary of Product Characteristics..
19. Tamoxifen for the management of breast events induced by non-steroidal antiandrogens in patients with prostate cancer: a systematic review. BMC Medicine..
20. A randomized trial comparing tamoxifen therapy vs. tamoxifen prophylaxis in bicalutamide-induced gynecomastia. Clinical Genitourinary Cancer..
21. Gynaecomastia in HIV-infected men on highly active antiretroviral therapy..

Frequently Asked Questions